Insider: Gould Robert J Director - Fulcrum Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 454,864 | 0 | 454,864 |
| Value | $3,541,116.24 | $0.00 | $3,541,116.24 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/02/2026 | DDS | 15,000 | Direct | COM | $10.72 | $160,857.00 | 454,864 |
| 01/02/2026 | DDS | 15,000 | Direct | COM | $11.87 | $178,089.00 | 469,864 |
| 11/19/2025 | DDS | 15,000 | Direct | COM | $11.03 | $165,495.00 | 484,864 |
| 01/13/2023 | DDS | 6,766 | Direct | COM | $15.00 | $101,490.00 | 499,864 |
| 06/07/2022 | DDS | 71,435 | Direct | COM | $8.09 | $577,894.86 | 506,630 |
| 06/06/2022 | DDS | 24,382 | Direct | COM | $8.10 | $197,591.73 | 506,630 |
| 06/03/2022 | DDS | 25,551 | Direct | COM | $7.95 | $203,056.35 | 506,630 |
| 06/02/2022 | DDS | 16,689 | Direct | COM | $7.92 | $132,161.86 | 506,630 |
| 04/07/2022 | DDS | 5,631 | Direct | COM | $24.02 | $135,228.47 | 506,630 |
| 04/05/2022 | DDS | 52,552 | Direct | COM | $24.26 | $1,274,774.88 | 506,630 |
| 04/04/2022 | DDS | 7,235 | Direct | COM | $24.02 | $173,749.25 | 506,630 |
| 04/01/2022 | DDS | 34,464 | Direct | COM | $24.03 | $828,159.58 | 506,630 |
| 03/16/2021 | DDS | 789 | Direct | COM | $12.43 | $9,805.61 | 506,630 |
| 03/15/2021 | DDS | 9,211 | Direct | COM | $12.13 | $111,772.72 | 507,419 |
| 02/16/2021 | DDS | 6,542 | Direct | COM | $14.19 | $92,830.33 | 518,303 |
| 02/16/2021 | DDS | 1,673 | Direct | COM | $14.56 | $24,367.08 | 516,630 |
| 01/20/2021 | DDS | 10,000 | Direct | COM | $12.08 | $120,826.00 | 524,845 |
| 07/08/2020 | DDS | 2,500 | Direct | COM | $20.00 | $50,000.00 | 534,845 |
| 06/25/2020 | DDS | 2,500 | Direct | COM | $20.80 | $51,992.00 | 537,345 |
| 06/25/2020 | DDS | 2,500 | Direct | COM | $20.80 | $51,992.00 | 537,345 |
| 06/09/2020 | DDS | 156 | Direct | COM | $20.00 | $3,120.00 | 539,845 |
| 06/05/2020 | DDS | 3,433 | Direct | COM | $20.17 | $69,251.16 | 540,001 |
| 06/04/2020 | DDS | 1,300 | Direct | COM | $20.04 | $26,057.98 | 543,434 |
| 06/03/2020 | DDS | 1,500 | Direct | COM | $20.13 | $30,192.45 | 544,734 |
| 06/02/2020 | DDS | 2,797 | Direct | COM | $20.00 | $55,940.00 | 546,234 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research